Innate Pharma S.A. (EPA:IPH)
2.200
+0.100 (4.76%)
Feb 21, 2025, 5:37 PM CET
Innate Pharma Revenue
Innate Pharma had revenue of 12.35M EUR in the half year ending June 30, 2024, a decrease of -72.92%. This brings the company's revenue in the last twelve months to 33.79M, down -35.37% year-over-year. In the year 2023, Innate Pharma had annual revenue of 61.64M with 6.88% growth.
Revenue (ttm)
33.79M
Revenue Growth
-35.37%
P/S Ratio
5.26
Revenue / Employee
201.12K
Employees
179
Market Cap
184.39M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 61.64M | 3.97M | 6.88% |
Dec 31, 2022 | 57.67M | 32.97M | 133.47% |
Dec 31, 2021 | 24.70M | -45.07M | -64.60% |
Dec 31, 2020 | 69.77M | -15.68M | -18.35% |
Dec 31, 2019 | 85.45M | -8.50M | -9.05% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 26.51B |
Sanofi | 44.29B |
Sartorius Stedim Biotech | 2.78B |
bioMérieux | 3.81B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.34B |
emeis Société anonyme | 5.43B |
Innate Pharma News
- 3 days ago - Innate Pharma and Merus gets FDA Breakthrough Therapy Designation for their respective treatments - Seeking Alpha
- 5 days ago - Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome - Business Wire
- 26 days ago - Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
- 26 days ago - Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors - Business Wire
- 4 weeks ago - Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York - Business Wire
- 6 weeks ago - Innate Pharma Announces Transformative Strategy to Accelerate Growth - Business Wire
- 2 months ago - Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Innate Pharma presents lacutamab improved health-related quality of life data at ASH 2024 - Seeking Alpha